Intestamin®

Intestamin®

Intestamin®

Features

Patented Formula
High in glutamine in the form of dipeptides (30 g/RDD*)
High in antioxidants: vitamins C and E, ß-carotene, zinc and selenium
With tributyrin, a precursor of butyrate
Low daily dosage (500 ml)
Suitable only for supplementary nutrition
Fibre-free
Unflavoured

^{* RDD = Recommended daily dosage}

Indications

For critically ill patients with or at risk of SIRS** or sepsis and with:

Severe or multiple trauma
Major abdominal surgery
Malnourishment
Serious burns
Acute severe pancreatitis

^{** SIRS = systemic inflammatory response syndrome}

Packaging

500 ml EasyBag

Dosage

Recommended daily dosage
For supplementary nutrition	500 ml	250 kcal
The product is not suitable as a sole source of nutrition. Therefore addition of enteral tube feeds or parenteral solutions is mandatory!

Product Characteristics

Energy density	0.5 kcal/ml
Key nutrients
Glutamine	6 g/100 ml
Vitamin C	300 mg/100 ml
Vitamin E	100 mg/100 ml
ß-carotene	2 mg/100 ml
Zinc	4 mg/100 ml
Selenium	60 μg/100 ml
Tributyrin	200 mg/100 ml

Library

Schroeder J., Alteheld B., Stehle P., Cayeux M-C., Chioléro R.L., Berger M.M.

^{European Journal of Clinical Nutrition (2005) 59, p. 307–310}

Safety and intestinal tolerance of high-dose enteral antioxidants and glutamine peptides after upper gastrointestinal surgery (0.1 MB)

Soguel L., Chioléro R., Revelly J.P., Eggimann P., Berger M.M.

^{Abstract SSMI / SGI}

Testing a glutamine selenium and zinc containing enteral supplement after major trauma and burns – preliminary data (0.2 MB)

Fürst P., Martindale R.G., Biesalski H.K., Suchner U.

^{Abstractbook Fresenius Kabi}

Symposium on "Early enteral nutrition of the critically ill - advantages and pitfalls" (0.3 MB)

Kudlich T.

^{Clinical Nutrition 2003; Vol. 22 (Suppl. 1), p. 75}

Intestamin inhibits proliferation and induces differentiation in colorectal carcinoma and adenoma cell lines (41 KB)

Berger M.M. Goette J., Stehle P., Cayeux M., Chiolero R., Schroeder J.

^{Clinical Nutrition 2002; Vol. 21, p. 73 (Suppl. 1)}

P-133 Safety and tolerance of an early enteral antioxidant and glutamine solution after major upper gastrointestinal surgery (22 KB)

Berger M.M. Goette J., Stehle P., Cayeux M., Chiolero R., Schroeder J.

^{Clinical Nutrition 2002; Vol. 21, p. 17 (Suppl. 1)}

P-073 Enteral absorption of a solution with high dose antioxidants and glutamine early after major upper gastrointestinal surgery (35 KB)

Senkal M., Deska T., Hummel T., Steinfort C., Stehle P., Zumtobel V.

^{Clinical Nutrition 2002; Vol. 21, p. 75 (Suppl. 1)}

P-159 Safety and tolerance of a low volume, high concentrated enteral supplement provides early after major abdominal surgery (29 KB)

Scheppach W., Plauth M., Mühlhöfer A., Weimann A., Rubin D., Faust D., Schauber J., Stein J. and Intestamin® Study Group

^{Clinical Nutrition 2003; Vol. 22, p. 32 (Suppl. 1)}

P-118 Intestamin and acute pancreatitis (35 KB)

Senkal M., Haaker R., Deska T., Hummel T., Steinforta C., Zumtobel V., Alteheld B., Stehle P.

^{Clinical Nutrition 2004; 23:1193-1198}

Early enteral gut feeding with conditionally indispensable pharmaconutrients is metabolically safe and is well tolerated in postoperative cancer patients - a pilot study (0.1 MB)

Beale R., Sherry T., Lei K., Campbell-Stephen L., McCook J., Smith J., Neilson A., Schneider H.

^{Crit. Care Med. 2004; 32(12)}

Early enteral supplementation with pharmaconutrients in critically ill patients (0.6 MB)